Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Mar;5(3):199-206.
doi: 10.1111/j.1365-2125.1978.tb01624.x.

Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and asthmatic patients in vitro

Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and asthmatic patients in vitro

J K Greenacre et al. Br J Clin Pharmacol. 1978 Mar.

Abstract

1 A lymphocyte culture method has been developed for studying in vitro the effect of prolonged exposure (24 h) to isoprenaline (10(-8) to 10(-6) mol/l) and prostaglandin E1 (PGE1; 2.8 x 10(-6) mol/l). 2 The cyclic AMP response to isoprenaline is reduced by prolonged exposure to isoprenaline. The degree of desensitization is in proportion to the concentration of isoprenaline in the culture medium. 3 Culture with isoprenaline does not reduce the cyclic AMP response to PGE1. 4 Culture for 24 h with PGE1 (2.8 x 10(-6) mol/l) reduces the cyclic AMP response to PGE1. It also significantly reduces the response to isoprenaline. 5 Lymphocytes from asthmatic patients show a similar degree of desensitization to isoprenaline (after 24 h culture with isoprenaline) to that seen in lymphocytes from normal subjects. 6 A modified assay for phosphodiesterase (PDE) activity was developed. PDE activity increased 24.5% (P less than 0.02) after culture with PGE1 but was not significantly affected by culture with isoprenaline. 7 It is concluded that desensitization caused by prolonged exposure to various stimulators of adenylate cyclase is an event dependent on several components, not all of which are yet defined.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 1977 Jan;59(1):17-23 - PubMed
    1. Nature. 1975 Dec 4;258(5534):435-6 - PubMed
    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. Br Med J. 1974 Jan 19;1(5898):90-3 - PubMed
    1. Proc Natl Acad Sci U S A. 1972 Jan;69(1):269-73 - PubMed

LinkOut - more resources